Adult Dose of Ertapenem
The standard adult dose of ertapenem is 1 gram intravenously once daily, administered over 30 minutes 1.
Standard Dosing Regimen
For adults 13 years and older with normal renal function (creatinine clearance >90 mL/min/1.73 m²), ertapenem is dosed at 1 g IV every 24 hours 2, 3, 4, 1. This once-daily dosing is a key advantage of ertapenem compared to other carbapenems that require more frequent administration 5.
Administration Details
- Infusion time: Standard 30-minute IV infusion 1
- Rapid infusion option: A 5-minute infusion has been shown to be bioequivalent and equally well-tolerated as the 30-minute infusion 6, though the standard remains 30 minutes per FDA labeling
- Intramuscular alternative: 1 g IM can be used when IV access is challenging, reconstituted with 3.2 mL of 1% lidocaine (without epinephrine) 1
Duration by Indication
Treatment duration varies by infection type 2, 1:
- Complicated intra-abdominal infections: 5-14 days
- Complicated skin/soft tissue infections: 7-14 days
- Community-acquired pneumonia: 10-14 days (may switch to oral after ≥3 days if clinically improved)
- Complicated urinary tract infections/pyelonephritis: 10-14 days
- Acute pelvic infections: 3-10 days
- Surgical prophylaxis (colorectal surgery): Single 1 g dose given 1 hour before incision 1, 7
Dose Adjustments
Renal Impairment
Critical adjustment required for severe renal dysfunction 1:
- CrCl >30 mL/min/1.73 m²: No adjustment needed (standard 1 g daily)
- CrCl ≤30 mL/min/1.73 m²: Reduce to 500 mg every 24 hours
- End-stage renal disease (CrCl ≤10 mL/min/1.73 m²): 500 mg every 24 hours
Hemodialysis Considerations
For patients on hemodialysis receiving the 500 mg daily dose 1:
- If ertapenem given within 6 hours before dialysis: Give supplementary 150 mg dose after dialysis
- If ertapenem given ≥6 hours before dialysis: No supplementary dose needed
Important caveat: A recent study found higher seizure risk (2.5%) in RRT patients, suggesting current dosing may still result in drug accumulation 8. Monitor closely for neurotoxicity.
Hepatic Impairment
No dose adjustment recommendations available due to insufficient data 1. However, since ertapenem undergoes minimal hepatic metabolism (only ~10% fecal excretion) 1, significant adjustment is unlikely needed for most patients with liver disease.
Obesity
Recent 2025 guidelines indicate no dose adjustment needed for obesity 9. While one study suggested insufficient target attainment in bariatric surgery patients, other studies showed adequate tissue concentrations with standard 1 g dosing. The modest pharmacokinetic changes do not warrant routine dose increases.
Special Populations
Pediatric Dosing (3 months to 12 years)
- 15 mg/kg twice daily (maximum 1 g/day total) 2, 1
- For ages 13-17 years: Use adult dose of 1 g daily 1
Elderly Patients
No dose adjustment needed based on age alone 1. The 37% increase in AUC observed in elderly patients is attributed to age-related decline in renal function. Adjust dose based on measured creatinine clearance, not age.
Clinical Considerations
Ertapenem is preferred over other carbapenems when single daily dosing is advantageous 10, particularly for:
- Outpatient parenteral antibiotic therapy (OPAT)
- Surgical prophylaxis requiring single-dose administration
- Antimicrobial stewardship (reserving meropenem/imipenem for more resistant organisms)
Key limitation: Ertapenem has limited stability (6-12 hours at 25°C depending on concentration) 5, requiring preparation shortly before administration and precluding continuous infusion strategies used with other beta-lactams.
Do not mix or co-infuse with other medications, and do not use dextrose-containing diluents 1. Reconstitute with 0.9% sodium chloride or water for injection only.